EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Concurrent Alcohol Use and the Relative Risk of Community‐Acquired Pneumonia Associated With Anticholinergic and Non‐Anticholinergic Neurocognitively Active Medication Receipt: A National Nested Case–Control Study Among US Veterans

William H Wang, Kristina Crothers, Kathleen M Akgün iD, Kirsha S Gordon, Maria C Rodriguez-Barradas, Julie A Womack, Jennifer Thompson, Amy C Justice, Christopher T Rentsch iD

Pharmacoepidemiology and Drug Safety · 2025

DOI: 10.1002/pds.70279 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2025. Verfasst von William H Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: London School of Hygiene & Tropical Medicine, London, UK. Hauptthemen laut MEDLINE: Cholinergic Antagonists, Veterans, Community-Acquired Infections, Pneumonia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAAA NIH HHS, National Institute on Alcohol Abuse and Alcoholism.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Anticholinergic medications and alcohol each independently increase the risk of community‐acquired pneumonia (CAP). Whether non‐anticholinergic neurocognitively active medications also increase risk, and if alcohol modifies these associations, remains unclear.

Methods

We conducted a nested case–control study using Veterans Aging Cohort Study (VACS)‐National data. We identified 157 185 incident CAP cases requiring hospitalization between 2010 and 2022. Cases were matched 1:5 to controls without CAP on demographics, cohort entry date, and dwell time in the underlying cohort study using incidence density (risk‐set) sampling. CAP index date was hospital admission for cases and the equivalent follow‐up date for controls. Primary exposures were receipt of anticholinergic and non‐anticholinergic neurocognitively active medications within 90 days prior to the index date. Concurrent alcohol use was based on self‐reported measures in the year prior to the index date. We estimated odds ratios (ORs) for associations between medication use, alcohol consumption, and CAP using logistic regression, adjusting for confounders.

Results

Median age was 69 years (interquartile range 62–78); 97% were male. Both medication types were independently associated with increased odds of CAP (anticholinergic: OR 1.62, 95% CI 1.57–1.67; non‐anticholinergic: OR 1.61, 95% CI 1.57–1.66). Concurrent alcohol use modified these associations. For anticholinergics, ORs were 1.74 (95% CI 1.66–1.83) for at‐risk consumption and 2.13 (95% CI 1.96–2.31) for hazardous/binge consumption. For non‐anticholinergics, ORs were 1.74 (95% CI 1.67–1.81) and 2.20 (95% CI 2.06–2.34), respectively.

Conclusions

Non‐anticholinergic neurocognitively active medications showed similar CAP association patterns as anticholinergics, with the highest odds among those consuming alcohol. These findings highlight the need for caution when prescribing these medications and incorporating alcohol use into risk–benefit assessments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholinergic AntagonistsVeteransCommunity-Acquired InfectionsPneumoniaAlcohol DrinkingHumansMaleCase-Control StudiesFemaleAgedUnited StatesMiddle AgedRisk FactorsCohort StudiesIncidenceHospitalizationAged, 80 and overCommunity-Acquired Pneumonia

Stichwörter der Autor:innen

alcohol drinkinganticholinergic agentscase–control studiesdrug interactionspneumoniapsychotropic drugsveterans

Substanzen

Cholinergic Antagonists

Autor:innen und Institutionen

  • London School of Hygiene & Tropical Medicine, London, UK.
  • VA Puget Sound Health Care System and University of Washington, Seattle, Washington, USA.
  • Yale School of Medicine, New Haven, Connecticut, USA.
  • VA Connecticut Healthcare System, West Haven, Connecticut, USA.
  • Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston, Texas, USA.
  • Yale School of Nursing, West Haven, Connecticut, USA.

ORCID-Profile: Kathleen M Akgün, Christopher T Rentsch

Förderung

  • NIAAA NIH HHS
  • National Institute on Alcohol Abuse and Alcoholism

Zitieren

APA

Wang, W. H., Crothers, K., Akgün, K. M., Gordon, K. S., Rodriguez-Barradas, M. C., Womack, J. A., Thompson, J., Justice, A. C., & Rentsch, C. T. (2025). Concurrent Alcohol Use and the Relative Risk of Community‐Acquired Pneumonia Associated With Anticholinergic and Non‐Anticholinergic Neurocognitively Active Medication Receipt: A National Nested Case–Control Study Among US Veterans. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.70279

Vancouver

Wang WH, Crothers K, Akgün KM, Gordon KS, Rodriguez-Barradas MC, Womack JA, et al. Concurrent Alcohol Use and the Relative Risk of Community‐Acquired Pneumonia Associated With Anticholinergic and Non‐Anticholinergic Neurocognitively Active Medication Receipt: A National Nested Case–Control Study Among US Veterans. Pharmacoepidemiology and Drug Safety. 2025. doi:10.1002/pds.70279

BibTeX
@article{Wang2025,
  author = {Wang, William H and Crothers, Kristina and Akgün, Kathleen M and Gordon, Kirsha S and Rodriguez-Barradas, Maria C and Womack, Julie A and Thompson, Jennifer and Justice, Amy C and Rentsch, Christopher T},
  title = {Concurrent Alcohol Use and the Relative Risk of Community‐Acquired Pneumonia Associated With Anticholinergic and Non‐Anticholinergic Neurocognitively Active Medication Receipt: A National Nested Case–Control Study Among US Veterans},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2025},
  doi = {10.1002/pds.70279}
}
Kostenlos starten →